NCBI Home Page NCBI Site Search page NCBI Guide that lists and describes the NCBI resources
Conserved domains on  [gi|22330618|ref|NP_177536|]
View 

TBP-associated factor 2 [Arabidopsis thaliana]

Protein Classification

Graphical summary

 Zoom to residue level

show extra options »

Show site features     Horizontal zoom: ×

List of domain hits

Name Accession Description Interval E-value
M1_like_TAF2 cd09839
TATA binding protein (TBP) associated factor 2; This family includes TATA binding protein (TBP) ...
25-509 2.73e-147

TATA binding protein (TBP) associated factor 2; This family includes TATA binding protein (TBP) associated factor 2 (TAF2, TBP-associated factor TAFII150, transcription initiation factor TFIID subunit 2, RNA polymerase II TBP-associated factor subunit B), and has homology to the M1 gluzincin family. TAF2 is part of the TFIID multidomain subunit complex essential for transcription of most protein-encoded genes by RNA polymerase II. TAF2 is known to interact with the initiator element (Inr) found at the transcription start site of many genes, thus possibly playing a key role in promoter binding as well as start-site selection. Image analysis has shown TAF2 to form a complex with TAF1 and TBP, inferring its role in promoter recognition. Peptidases in the M1 family bind a single catalytic zinc ion which is tetrahedrally co-ordinated by three amino acid ligands and a water molecule that forms the nucleophile on activation during catalysis. TAF2, however, lacks these active site residues.


:

Pssm-ID: 341074 [Multi-domain]  Cd Length: 531  Bit Score: 458.23  E-value: 2.73e-147
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 22330618   25 VLHQKLFLSIDFKKRQIYGYTELEV--SVPDIGIVGLHAENLGIESVLVDGEPTVFEYYPHHQNSETESNWNSVSDPASA 102
Cdd:cd09839    1 VAHQKVELDVDFANRSIIGYTEITIvpTSPDLRTIRLNCRQCKIKSVTVNGVEAEFTYNDPLQNLDLSDNTDVNAHHELK 80
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 22330618  103 ADAAameYVGVLKREDTANLLINCCKPSKDLSEQLDSVT--LENGSQSSGEAKQNVKLIRINYWVEKIESGIHFDGN--- 177
Cdd:cd09839   81 RKLA---AALAEPDEGNEELVISLPPSVKIELQDPNSAStqATTSSPDTSEDEFTPLTIRIEYSLKNPRDGLHFVGPdeg 157
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 22330618  178 ------IVHTDNQM--RRARCWFPCIDDEYHRCSFDLEFTVPH-----------------------------NFVAVSVG 220
Cdd:cd09839  158 gdkrypHVYTTNSPlpGSARCWFPCVDSLWERCTWELEITVPRtlgdagrpplagskededdddlteedkelEMVVVCSG 237
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 22330618  221 KLLYQVMCKEDTTQKTYVYELAIPIAPRWVSLVAGPLEILPD-------------QTNFLISNLCLPHDLSRLRNTMEFF 287
Cdd:cd09839  238 DLVEQVVHPEDPSKKTFSFSLSNPTSAQHIGFAVGPFEIVPLpefreseeddklgSSAVEVTGFCLPGRLEELRNTCSFL 317
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 22330618  288 HEAYSYYEDYlSANFPFGFYKQVFLppEMVVTSSTSGASLSIFSSHILYDERVIDQTIDTRIKLASALAKQWFGVYITPE 367
Cdd:cd09839  318 HKAMDFFEEE-YGSYPFSSYKQVFV--DDLPEDVSSFASLSICSSRLLYPPDIIDQAYETRRKLAHALASQWFGINIIPK 394
                        410       420       430       440       450       460       470       480
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 22330618  368 SPNDDWLLDGLAGFLTDMFIKQFLGNNEARYRRYKANCAVCKADDSGAmclsssPSCRDLFGTHSIGMHGKIRSWKSGAV 447
Cdd:cd09839  395 TWSDTWLVIGIAGYMTGLFLKKLFGNNEYRFRIKKDADRVCELDIGRP------PLAQPGFILPLDPSELEFMALKAPLV 468
                        490       500       510       520       530       540
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 22330618  448 LQMLEKQMGSDSFRKILQKIISR----AKDPSNSIRSLSTKEFRQFANKIGnleRPFLKEFFQRWV 509
Cdd:cd09839  469 LFILDRRLTKTGGSFGLSRVLPKiflqAMSGDLSNNALSTSHFLRTCEKVS---GNKLESFFDQWV 531
KLF3_N super family cl40586
N-terminal domain of Kruppel-like factor 3; Kruppel-like factor 3 (KLF3; also called ...
1041-1144 4.03e-03

N-terminal domain of Kruppel-like factor 3; Kruppel-like factor 3 (KLF3; also called Krueppel-like factor 3 and originally called Basic Kruppel-like Factor/BKLF), was the third member of the KLF family of zinc finger transcription factors to be discovered. KLF3 possesses a wide range of biological impacts on regulating apoptosis, differentiation, and proliferation in various tissues during the entire progression process. It has been proposed as a tumor suppressor in colorectal cancer. It appears to function predominantly as a repressor of transcription, turning genes off by recruiting the C-terminal Binding Protein co-repressors CtBP1 and CtBP2. CtBP docks onto a short motif (residues 61-65) in the N-terminus of KLF3, through the Proline-X-Aspartate-Leucine-Serine (PXDLS) motif. CtBP in turn recruits histone modifying enzymes to alter chromatin and repress gene expression. KLF3 belongs to a family of proteins, called the Specificity Protein (SP)/KLF family, characterized by a C-terminal DNA-binding domain of 81 amino acids consisting of three Kruppel-like C2H2 zinc fingers. These factors bind to a loose consensus motif, namely NNRCRCCYY (where N is any nucleotide; R is A/G, and Y is C/T), such as the recurring motifs in GC and GT boxes (5'-GGGGCGGGG-3' and 5-GGTGTGGGG-3') that are present in promoters and more distal regulatory elements of mammalian genes. Members of the KLF family can act as activators or repressors of transcription depending on cell and promoter context. KLFs regulate various cellular functions, such as proliferation, differentiation, and apoptosis, as well as the development and homeostasis of several types of tissue. In addition to the C-terminal DNA-binding domain, each KLF also has a unique N-terminal activation/repression domain that confers specificity and allows it to bind specifically to a certain partner, leading to distinct activities in vivo. This model represents the N-terminal domain of KLF3.


The actual alignment was detected with superfamily member cd21577:

Pssm-ID: 410554 [Multi-domain]  Cd Length: 214  Bit Score: 40.41  E-value: 4.03e-03
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 22330618 1041 SLDVAPYGVPIIPQEMFMPIVPELMLPEPVAAYdetQHL--------EPRMESQNQPSHENPIVH-EIPSDvegpteela 1111
Cdd:cd21577   81 PPVAPPPLSPGSVPGGLPVISPVMVQPVPVLYP---PHLhqpimvssSPPPDDDHHHHKASSMKPsELGGD--------- 148
                         90       100       110
                 ....*....|....*....|....*....|....
gi 22330618 1112 HREANPPTK-EPQkePDVVSVSVSHEVKKSVIRI 1144
Cdd:cd21577  149 NHELHKPIKtEPR--PEHAQDPYSEEMSSSVISS 180
 
Name Accession Description Interval E-value
M1_like_TAF2 cd09839
TATA binding protein (TBP) associated factor 2; This family includes TATA binding protein (TBP) ...
25-509 2.73e-147

TATA binding protein (TBP) associated factor 2; This family includes TATA binding protein (TBP) associated factor 2 (TAF2, TBP-associated factor TAFII150, transcription initiation factor TFIID subunit 2, RNA polymerase II TBP-associated factor subunit B), and has homology to the M1 gluzincin family. TAF2 is part of the TFIID multidomain subunit complex essential for transcription of most protein-encoded genes by RNA polymerase II. TAF2 is known to interact with the initiator element (Inr) found at the transcription start site of many genes, thus possibly playing a key role in promoter binding as well as start-site selection. Image analysis has shown TAF2 to form a complex with TAF1 and TBP, inferring its role in promoter recognition. Peptidases in the M1 family bind a single catalytic zinc ion which is tetrahedrally co-ordinated by three amino acid ligands and a water molecule that forms the nucleophile on activation during catalysis. TAF2, however, lacks these active site residues.


Pssm-ID: 341074 [Multi-domain]  Cd Length: 531  Bit Score: 458.23  E-value: 2.73e-147
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 22330618   25 VLHQKLFLSIDFKKRQIYGYTELEV--SVPDIGIVGLHAENLGIESVLVDGEPTVFEYYPHHQNSETESNWNSVSDPASA 102
Cdd:cd09839    1 VAHQKVELDVDFANRSIIGYTEITIvpTSPDLRTIRLNCRQCKIKSVTVNGVEAEFTYNDPLQNLDLSDNTDVNAHHELK 80
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 22330618  103 ADAAameYVGVLKREDTANLLINCCKPSKDLSEQLDSVT--LENGSQSSGEAKQNVKLIRINYWVEKIESGIHFDGN--- 177
Cdd:cd09839   81 RKLA---AALAEPDEGNEELVISLPPSVKIELQDPNSAStqATTSSPDTSEDEFTPLTIRIEYSLKNPRDGLHFVGPdeg 157
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 22330618  178 ------IVHTDNQM--RRARCWFPCIDDEYHRCSFDLEFTVPH-----------------------------NFVAVSVG 220
Cdd:cd09839  158 gdkrypHVYTTNSPlpGSARCWFPCVDSLWERCTWELEITVPRtlgdagrpplagskededdddlteedkelEMVVVCSG 237
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 22330618  221 KLLYQVMCKEDTTQKTYVYELAIPIAPRWVSLVAGPLEILPD-------------QTNFLISNLCLPHDLSRLRNTMEFF 287
Cdd:cd09839  238 DLVEQVVHPEDPSKKTFSFSLSNPTSAQHIGFAVGPFEIVPLpefreseeddklgSSAVEVTGFCLPGRLEELRNTCSFL 317
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 22330618  288 HEAYSYYEDYlSANFPFGFYKQVFLppEMVVTSSTSGASLSIFSSHILYDERVIDQTIDTRIKLASALAKQWFGVYITPE 367
Cdd:cd09839  318 HKAMDFFEEE-YGSYPFSSYKQVFV--DDLPEDVSSFASLSICSSRLLYPPDIIDQAYETRRKLAHALASQWFGINIIPK 394
                        410       420       430       440       450       460       470       480
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 22330618  368 SPNDDWLLDGLAGFLTDMFIKQFLGNNEARYRRYKANCAVCKADDSGAmclsssPSCRDLFGTHSIGMHGKIRSWKSGAV 447
Cdd:cd09839  395 TWSDTWLVIGIAGYMTGLFLKKLFGNNEYRFRIKKDADRVCELDIGRP------PLAQPGFILPLDPSELEFMALKAPLV 468
                        490       500       510       520       530       540
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 22330618  448 LQMLEKQMGSDSFRKILQKIISR----AKDPSNSIRSLSTKEFRQFANKIGnleRPFLKEFFQRWV 509
Cdd:cd09839  469 LFILDRRLTKTGGSFGLSRVLPKiflqAMSGDLSNNALSTSHFLRTCEKVS---GNKLESFFDQWV 531
PepN COG0308
Aminopeptidase N, contains DUF3458 domain [Amino acid transport and metabolism];
20-528 8.12e-40

Aminopeptidase N, contains DUF3458 domain [Amino acid transport and metabolism];


Pssm-ID: 440077 [Multi-domain]  Cd Length: 609  Bit Score: 157.50  E-value: 8.12e-40
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 22330618   20 NTGAKVLHQKLFLSIDFKKRQIYGYTELEVSV--PDIGIVGLHAENLGIESVLVDGEPTVFEYyphhqnsetESNWNSVS 97
Cdd:COG0308   12 PPGYDVTHYDLDLDLDPATTRLSGTATITFTAteAPLDSLVLDLKGLEVTSVTVDGKPLDFTR---------DGERLTIT 82
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 22330618   98 DPasaadaaameyvGVLKREDTANLLI-NCCKPSKDLSeqldsvTLengsqssgeakqnvklirinYWVEKIESGIHFdg 176
Cdd:COG0308   83 LP------------KPLAPGETFTLEIeYSGKPSNGGE------GL--------------------YRSGDPPDGPPY-- 122
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 22330618  177 niVHTDNQMRRARCWFPCIDDEYHRCSFDLEFTVPHNFVAVSVGKLLYQVmcKEDTTQKTYVYELAIPIAPRWVSLVAGP 256
Cdd:COG0308  123 --LYTQCEPEGARRWFPCFDHPDDKATFTLTVTVPAGWVAVSNGNLVSET--ELGDGRTTWHWADTQPIPTYLFALAAGD 198
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 22330618  257 LEILPDQT--NFLISNLCLPHDLSRLRNTMEFFHEAYSYYEDYLSANFPFGFYKQVFLPpemvvtSSTSGA----SLSIF 330
Cdd:COG0308  199 YAVVEDTFasGVPLRVYVRPGLADKAKEAFESTKRMLDFFEELFGVPYPFDKYDQVAVP------DFNFGAmenqGLVTF 272
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 22330618  331 SSHILYDERVIDQTIDTRIKL-ASALAKQWFGVYITPESPNDDWLLDGLAGFLTDMFIKQFLGNNEARYRRYKANCAVCK 409
Cdd:COG0308  273 GEKVLADETATDADYERRESViAHELAHQWFGNLVTCADWDDLWLNEGFATYMEQLFSEDLYGKDAADRIFVGALRSYAF 352
                        410       420       430       440       450       460       470       480
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 22330618  410 ADDSGAMclssspscrdlfgTHSIGMHGKIRSW---------KSGAVLQMLEKQMGSDSFRKILQKIISRAKDpsnsiRS 480
Cdd:COG0308  353 AEDAGPN-------------AHPIRPDDYPEIEnffdgivyeKGALVLHMLRTLLGDEAFRAGLRLYFARHAG-----GN 414
                        490       500       510       520
                 ....*....|....*....|....*....|....*....|....*...
gi 22330618  481 LSTKEFRQFANKIGNLErpfLKEFFQRWVASYGCPVLRIGLSYNKRKN 528
Cdd:COG0308  415 ATTEDFLAALEEASGRD---LSAFFDQWLYQAGLPTLEVEYEYDADGK 459
Peptidase_M1 pfam01433
Peptidase family M1 domain; Members of this family are aminopeptidases. The members differ ...
283-508 8.59e-11

Peptidase family M1 domain; Members of this family are aminopeptidases. The members differ widely in specificity, hydrolysing acidic, basic or neutral N-terminal residues. This family includes leukotriene-A4 hydrolase, this enzyme also has an aminopeptidase activity.


Pssm-ID: 426262 [Multi-domain]  Cd Length: 219  Bit Score: 63.46  E-value: 8.59e-11
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 22330618    283 TMEFFHEAYSYYEDYLSANFPFGFYKQVFLPpemvvtSSTSGA----SLSIF-SSHILYDERVidQTIDTRIKLASA--- 354
Cdd:pfam01433    2 ALEITVKLLEFYEDYFNIPYPLPKYDLVALP------DFSAGAmenwGLITYrETLLLYDPGN--SSTSDKQRVASViah 73
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 22330618    355 -LAKQWFGVYITPESPNDDWLLDGLAGFLTDMFIKQFLGNNE--ARYRRYKANcavckaddsGAMCLSSSPScrdlfgTH 431
Cdd:pfam01433   74 eLAHQWFGNLVTMKWWDDLWLNEGFATYMEYLGTDALFPEWNiwEQFLLDEVQ---------NAMARDALDS------SH 138
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 22330618    432 SIGMH-------GKIRSW----KSGAVLQMLEKQMGSDSFRKILQKIISRAK----DPSNSIRSLStkefrQFANKIGnl 496
Cdd:pfam01433  139 PITQNvndpseiDDIFDAipyeKGASVLRMLETLLGEEVFQKGLRSYLKKFQygnaTTEDLWDALS-----EASGPLD-- 211
                          250
                   ....*....|..
gi 22330618    497 erpfLKEFFQRW 508
Cdd:pfam01433  212 ----VDSFMDTW 219
KLF3_N cd21577
N-terminal domain of Kruppel-like factor 3; Kruppel-like factor 3 (KLF3; also called ...
1041-1144 4.03e-03

N-terminal domain of Kruppel-like factor 3; Kruppel-like factor 3 (KLF3; also called Krueppel-like factor 3 and originally called Basic Kruppel-like Factor/BKLF), was the third member of the KLF family of zinc finger transcription factors to be discovered. KLF3 possesses a wide range of biological impacts on regulating apoptosis, differentiation, and proliferation in various tissues during the entire progression process. It has been proposed as a tumor suppressor in colorectal cancer. It appears to function predominantly as a repressor of transcription, turning genes off by recruiting the C-terminal Binding Protein co-repressors CtBP1 and CtBP2. CtBP docks onto a short motif (residues 61-65) in the N-terminus of KLF3, through the Proline-X-Aspartate-Leucine-Serine (PXDLS) motif. CtBP in turn recruits histone modifying enzymes to alter chromatin and repress gene expression. KLF3 belongs to a family of proteins, called the Specificity Protein (SP)/KLF family, characterized by a C-terminal DNA-binding domain of 81 amino acids consisting of three Kruppel-like C2H2 zinc fingers. These factors bind to a loose consensus motif, namely NNRCRCCYY (where N is any nucleotide; R is A/G, and Y is C/T), such as the recurring motifs in GC and GT boxes (5'-GGGGCGGGG-3' and 5-GGTGTGGGG-3') that are present in promoters and more distal regulatory elements of mammalian genes. Members of the KLF family can act as activators or repressors of transcription depending on cell and promoter context. KLFs regulate various cellular functions, such as proliferation, differentiation, and apoptosis, as well as the development and homeostasis of several types of tissue. In addition to the C-terminal DNA-binding domain, each KLF also has a unique N-terminal activation/repression domain that confers specificity and allows it to bind specifically to a certain partner, leading to distinct activities in vivo. This model represents the N-terminal domain of KLF3.


Pssm-ID: 410554 [Multi-domain]  Cd Length: 214  Bit Score: 40.41  E-value: 4.03e-03
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 22330618 1041 SLDVAPYGVPIIPQEMFMPIVPELMLPEPVAAYdetQHL--------EPRMESQNQPSHENPIVH-EIPSDvegpteela 1111
Cdd:cd21577   81 PPVAPPPLSPGSVPGGLPVISPVMVQPVPVLYP---PHLhqpimvssSPPPDDDHHHHKASSMKPsELGGD--------- 148
                         90       100       110
                 ....*....|....*....|....*....|....
gi 22330618 1112 HREANPPTK-EPQkePDVVSVSVSHEVKKSVIRI 1144
Cdd:cd21577  149 NHELHKPIKtEPR--PEHAQDPYSEEMSSSVISS 180
 
Name Accession Description Interval E-value
M1_like_TAF2 cd09839
TATA binding protein (TBP) associated factor 2; This family includes TATA binding protein (TBP) ...
25-509 2.73e-147

TATA binding protein (TBP) associated factor 2; This family includes TATA binding protein (TBP) associated factor 2 (TAF2, TBP-associated factor TAFII150, transcription initiation factor TFIID subunit 2, RNA polymerase II TBP-associated factor subunit B), and has homology to the M1 gluzincin family. TAF2 is part of the TFIID multidomain subunit complex essential for transcription of most protein-encoded genes by RNA polymerase II. TAF2 is known to interact with the initiator element (Inr) found at the transcription start site of many genes, thus possibly playing a key role in promoter binding as well as start-site selection. Image analysis has shown TAF2 to form a complex with TAF1 and TBP, inferring its role in promoter recognition. Peptidases in the M1 family bind a single catalytic zinc ion which is tetrahedrally co-ordinated by three amino acid ligands and a water molecule that forms the nucleophile on activation during catalysis. TAF2, however, lacks these active site residues.


Pssm-ID: 341074 [Multi-domain]  Cd Length: 531  Bit Score: 458.23  E-value: 2.73e-147
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 22330618   25 VLHQKLFLSIDFKKRQIYGYTELEV--SVPDIGIVGLHAENLGIESVLVDGEPTVFEYYPHHQNSETESNWNSVSDPASA 102
Cdd:cd09839    1 VAHQKVELDVDFANRSIIGYTEITIvpTSPDLRTIRLNCRQCKIKSVTVNGVEAEFTYNDPLQNLDLSDNTDVNAHHELK 80
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 22330618  103 ADAAameYVGVLKREDTANLLINCCKPSKDLSEQLDSVT--LENGSQSSGEAKQNVKLIRINYWVEKIESGIHFDGN--- 177
Cdd:cd09839   81 RKLA---AALAEPDEGNEELVISLPPSVKIELQDPNSAStqATTSSPDTSEDEFTPLTIRIEYSLKNPRDGLHFVGPdeg 157
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 22330618  178 ------IVHTDNQM--RRARCWFPCIDDEYHRCSFDLEFTVPH-----------------------------NFVAVSVG 220
Cdd:cd09839  158 gdkrypHVYTTNSPlpGSARCWFPCVDSLWERCTWELEITVPRtlgdagrpplagskededdddlteedkelEMVVVCSG 237
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 22330618  221 KLLYQVMCKEDTTQKTYVYELAIPIAPRWVSLVAGPLEILPD-------------QTNFLISNLCLPHDLSRLRNTMEFF 287
Cdd:cd09839  238 DLVEQVVHPEDPSKKTFSFSLSNPTSAQHIGFAVGPFEIVPLpefreseeddklgSSAVEVTGFCLPGRLEELRNTCSFL 317
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 22330618  288 HEAYSYYEDYlSANFPFGFYKQVFLppEMVVTSSTSGASLSIFSSHILYDERVIDQTIDTRIKLASALAKQWFGVYITPE 367
Cdd:cd09839  318 HKAMDFFEEE-YGSYPFSSYKQVFV--DDLPEDVSSFASLSICSSRLLYPPDIIDQAYETRRKLAHALASQWFGINIIPK 394
                        410       420       430       440       450       460       470       480
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 22330618  368 SPNDDWLLDGLAGFLTDMFIKQFLGNNEARYRRYKANCAVCKADDSGAmclsssPSCRDLFGTHSIGMHGKIRSWKSGAV 447
Cdd:cd09839  395 TWSDTWLVIGIAGYMTGLFLKKLFGNNEYRFRIKKDADRVCELDIGRP------PLAQPGFILPLDPSELEFMALKAPLV 468
                        490       500       510       520       530       540
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 22330618  448 LQMLEKQMGSDSFRKILQKIISR----AKDPSNSIRSLSTKEFRQFANKIGnleRPFLKEFFQRWV 509
Cdd:cd09839  469 LFILDRRLTKTGGSFGLSRVLPKiflqAMSGDLSNNALSTSHFLRTCEKVS---GNKLESFFDQWV 531
PepN COG0308
Aminopeptidase N, contains DUF3458 domain [Amino acid transport and metabolism];
20-528 8.12e-40

Aminopeptidase N, contains DUF3458 domain [Amino acid transport and metabolism];


Pssm-ID: 440077 [Multi-domain]  Cd Length: 609  Bit Score: 157.50  E-value: 8.12e-40
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 22330618   20 NTGAKVLHQKLFLSIDFKKRQIYGYTELEVSV--PDIGIVGLHAENLGIESVLVDGEPTVFEYyphhqnsetESNWNSVS 97
Cdd:COG0308   12 PPGYDVTHYDLDLDLDPATTRLSGTATITFTAteAPLDSLVLDLKGLEVTSVTVDGKPLDFTR---------DGERLTIT 82
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 22330618   98 DPasaadaaameyvGVLKREDTANLLI-NCCKPSKDLSeqldsvTLengsqssgeakqnvklirinYWVEKIESGIHFdg 176
Cdd:COG0308   83 LP------------KPLAPGETFTLEIeYSGKPSNGGE------GL--------------------YRSGDPPDGPPY-- 122
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 22330618  177 niVHTDNQMRRARCWFPCIDDEYHRCSFDLEFTVPHNFVAVSVGKLLYQVmcKEDTTQKTYVYELAIPIAPRWVSLVAGP 256
Cdd:COG0308  123 --LYTQCEPEGARRWFPCFDHPDDKATFTLTVTVPAGWVAVSNGNLVSET--ELGDGRTTWHWADTQPIPTYLFALAAGD 198
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 22330618  257 LEILPDQT--NFLISNLCLPHDLSRLRNTMEFFHEAYSYYEDYLSANFPFGFYKQVFLPpemvvtSSTSGA----SLSIF 330
Cdd:COG0308  199 YAVVEDTFasGVPLRVYVRPGLADKAKEAFESTKRMLDFFEELFGVPYPFDKYDQVAVP------DFNFGAmenqGLVTF 272
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 22330618  331 SSHILYDERVIDQTIDTRIKL-ASALAKQWFGVYITPESPNDDWLLDGLAGFLTDMFIKQFLGNNEARYRRYKANCAVCK 409
Cdd:COG0308  273 GEKVLADETATDADYERRESViAHELAHQWFGNLVTCADWDDLWLNEGFATYMEQLFSEDLYGKDAADRIFVGALRSYAF 352
                        410       420       430       440       450       460       470       480
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 22330618  410 ADDSGAMclssspscrdlfgTHSIGMHGKIRSW---------KSGAVLQMLEKQMGSDSFRKILQKIISRAKDpsnsiRS 480
Cdd:COG0308  353 AEDAGPN-------------AHPIRPDDYPEIEnffdgivyeKGALVLHMLRTLLGDEAFRAGLRLYFARHAG-----GN 414
                        490       500       510       520
                 ....*....|....*....|....*....|....*....|....*...
gi 22330618  481 LSTKEFRQFANKIGNLErpfLKEFFQRWVASYGCPVLRIGLSYNKRKN 528
Cdd:COG0308  415 ATTEDFLAALEEASGRD---LSAFFDQWLYQAGLPTLEVEYEYDADGK 459
M1_APN_like cd09603
Peptidase M1 family similar to aminopeptidase N catalytic domain; This family contains mostly ...
25-509 1.48e-35

Peptidase M1 family similar to aminopeptidase N catalytic domain; This family contains mostly bacterial and some archaeal M1 peptidases with smilarity to the catalytic domain of aminopeptidase N (APN; CD13; alanyl aminopeptidase; EC 3.4.11.2), a type II integral membrane protease belonging to the M1 gluzincin family. APN preferentially cleaves neutral amino acids from the N-terminus of oligopeptides and, in higher eukaryotes, is present in a variety of human tissues and cell types (leukocyte, fibroblast, endothelial and epithelial cells). APN expression is dysregulated in inflammatory diseases such as chronic pain, rheumatoid arthritis, multiple sclerosis, systemic sclerosis, systemic lupus erythematosus, polymyositis/dermatomyosytis and pulmonary sarcoidosis, and is enhanced in tumor cells such as melanoma, renal, prostate, pancreas, colon, gastric and thyroid cancers. It is predominantly expressed on stem cells and on cells of the granulocytic and monocytic lineages at distinct stages of differentiation, thus considered a marker of differentiation. Thus, APN inhibition may lead to the development of anti-cancer and anti-inflammatory drugs. APNs are also present in many pathogenic bacteria and represent potential drug targets. Some APNs have been used commercially, such as one from Lactococcus lactis used in the food industry. APN also serves as a receptor for coronaviruses, although the virus receptor interaction site seems to be distinct from the enzymatic site and aminopeptidase activity is not necessary for viral infection. APNs have also been extensively studied as putative Cry toxin receptors. Cry1 proteins are pore-forming toxins that bind to the midgut epithelial cell membrane of susceptible insect larvae, causing extensive damage. Several different toxins, including Cry1Aa, Cry1Ab, Cry1Ac, Cry1Ba, Cry1Ca and Cry1Fa, have been shown to bind to APNs; however, a direct role of APN in cytotoxicity has been yet to be firmly established.


Pssm-ID: 341066 [Multi-domain]  Cd Length: 410  Bit Score: 140.80  E-value: 1.48e-35
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 22330618   25 VLHQKLFLSIDFKKRQIYGYTELEVSVP-DIGIVGLHAENLGIESVLVDGEPTVFEYYphhqnsetesnwnsvsdpasaa 103
Cdd:cd09603    3 VLHYDLDLDYDPATKSLSGTATITFRATqDLDSLQLDLVGLTVSSVTVDGVPAAFFTH---------------------- 60
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 22330618  104 daaameyvgvlkredTANLLIncckpskdlseqldsVTLENGSQSSGEAKqnvklIRINY--------WVEKIESGIHFD 175
Cdd:cd09603   61 ---------------DGDKLV---------------ITLPRPLAAGETFT-----VTVRYsgkprpagYPPGDGGGWEEG 105
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 22330618  176 GNIVHTDNQMRRARCWFPCIDDEYHRCSFDLEFTVPHNFVAVSVGKLLYQVmcKEDTTQKTYVYELAIPIAPRWVSLVAG 255
Cdd:cd09603  106 DDGVWTAGQPEGASTWFPCNDHPDDKATYDITVTVPAGLTVVSNGRLVSTT--TNGGGTTTWHWKMDYPIATYLVTLAVG 183
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 22330618  256 PLEILPDQT--NFLISNLCLPHDLSRLRNTMEFFHEAYSYYEDYLsANFPFGFYKQVflppemvVTSSTSGA----SLSI 329
Cdd:cd09603  184 RYAVVEDGSggGIPLRYYVPPGDAAKAKASFARTPEMLDFFEELF-GPYPFEKYGQV-------VVPDLGGGmehqTATT 255
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 22330618  330 FSSHILYDERVIDQTIdtriklASALAKQWFGVYITPESPNDDWLLDGLAGFLTDMFIKQFLGNNEARYRRYKANCAVcK 409
Cdd:cd09603  256 YGNNFLNGDRGSERLI------AHELAHQWFGDSVTCADWADIWLNEGFATYAEWLWSEHKGGADAYRAYLAGQRQDY-L 328
                        410       420       430       440       450       460       470       480
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 22330618  410 ADDSGAMCLSSSpscRDLFGTHSigmhgkirSWKSGAVLQMLEKQMGSDSFRKILQKIISRAKDpsnsiRSLSTKEFRQF 489
Cdd:cd09603  329 NADPGPGRPPDP---DDLFDRDV--------YQKGALVLHMLRNLLGDEAFFAALRAYLARYAH-----GNVTTEDFIAA 392
                        490       500
                 ....*....|....*....|
gi 22330618  490 ANKIGNLErpfLKEFFQRWV 509
Cdd:cd09603  393 AEEVSGRD---LTWFFDQWL 409
M1 cd09595
Peptidase M1 family includes the catalytic domains of aminopeptidase N and leukotriene A4 ...
175-492 2.15e-16

Peptidase M1 family includes the catalytic domains of aminopeptidase N and leukotriene A4 hydrolase; The model represents the catalytic domains of M1 peptidase family members including aminopeptidase N (APN) and leukotriene A4 hydrolase (LTA4H). All peptidases in this family bind a single catalytic zinc ion which is tetrahedrally co-ordinated by three amino acid ligands and a water molecule that forms the nucleophile upon activation during catalysis. APN preferentially cleaves neutral amino acids from the N-terminus of oligopeptides and is present in a variety of human tissues and cell types. APN expression is dysregulated in many inflammatory diseases and is enhanced in numerous tumor cells, making it a lead target in the development of anti-cancer and anti-inflammatory drugs. LTA4H is a bifunctional enzyme, possessing an aminopeptidase as well as an epoxide hydrolase activity. The two activities occupy different, but overlapping sites. The activity and physiological relevance of the aminopeptidase in LTA4H is as yet unknown, while the epoxide hydrolase converts leukotriene A4 (LTA4) into leukotriene B4 (LTB4), a potent chemotaxin that is fundamental to the inflammatory response of mammals.


Pssm-ID: 341058 [Multi-domain]  Cd Length: 413  Bit Score: 83.26  E-value: 2.15e-16
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 22330618  175 DGNIVHTDNQMRRARCWFPCIDDEYHRCSFDLEFTVPHNFVAVSVGKLLYQVMCKEDTtqKTYVYELAIPIAPRWVSLVA 254
Cdd:cd09595  103 EKPYLFTQFEATHARRIFPCIDHPAVKATFTVTITTPKKDLLASNGALVGEETGANGR--KTYRFEDTPPIPTYLVAVVV 180
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 22330618  255 GPLEILPD----QTNFLISNLCLPHDLSRLRNTMEFFHEAYSYYEDYLSANFPFGFYKQVFLPPEMVV-----TSSTSGA 325
Cdd:cd09595  181 GDLEFKYVtvksQPRVGLSVYSEPLQVDQAQYAFDATRAALAWFEDYFGGPYPLPKYDLLAVPDFNSGamenpGLITFRT 260
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 22330618  326 SLSIFSSHILYDERVIDQTIdtriklASALAKQWFGVYITPESPNDDWLLDGLAGFLTDMFIKQFLGNNEARYRRYkanc 405
Cdd:cd09595  261 TYLLRSKVTDTGARSIENVI------AHELAHQWFGNLVTMRWWNDLWLNEGFAVYYENRIMDATFGTSSRHLDQL---- 330
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 22330618  406 avckaddSGAMCLSSSpscRDLFGTHSIGMhgKIRSW-------------KSGAVLQMLEKQMGSDSFRKILQKIISRak 472
Cdd:cd09595  331 -------SGSSDLNTE---QLLEDSSPTST--PVRSPadpdvaydgvtyaKGALVLRMLEELVGEEAFDKGVQAYFNR-- 396
                        330       340
                 ....*....|....*....|
gi 22330618  473 dpsNSIRSLSTKEFRQFANK 492
Cdd:cd09595  397 ---HKFKNATTDDFIDALEE 413
Peptidase_M1 pfam01433
Peptidase family M1 domain; Members of this family are aminopeptidases. The members differ ...
283-508 8.59e-11

Peptidase family M1 domain; Members of this family are aminopeptidases. The members differ widely in specificity, hydrolysing acidic, basic or neutral N-terminal residues. This family includes leukotriene-A4 hydrolase, this enzyme also has an aminopeptidase activity.


Pssm-ID: 426262 [Multi-domain]  Cd Length: 219  Bit Score: 63.46  E-value: 8.59e-11
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 22330618    283 TMEFFHEAYSYYEDYLSANFPFGFYKQVFLPpemvvtSSTSGA----SLSIF-SSHILYDERVidQTIDTRIKLASA--- 354
Cdd:pfam01433    2 ALEITVKLLEFYEDYFNIPYPLPKYDLVALP------DFSAGAmenwGLITYrETLLLYDPGN--SSTSDKQRVASViah 73
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 22330618    355 -LAKQWFGVYITPESPNDDWLLDGLAGFLTDMFIKQFLGNNE--ARYRRYKANcavckaddsGAMCLSSSPScrdlfgTH 431
Cdd:pfam01433   74 eLAHQWFGNLVTMKWWDDLWLNEGFATYMEYLGTDALFPEWNiwEQFLLDEVQ---------NAMARDALDS------SH 138
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 22330618    432 SIGMH-------GKIRSW----KSGAVLQMLEKQMGSDSFRKILQKIISRAK----DPSNSIRSLStkefrQFANKIGnl 496
Cdd:pfam01433  139 PITQNvndpseiDDIFDAipyeKGASVLRMLETLLGEEVFQKGLRSYLKKFQygnaTTEDLWDALS-----EASGPLD-- 211
                          250
                   ....*....|..
gi 22330618    497 erpfLKEFFQRW 508
Cdd:pfam01433  212 ----VDSFMDTW 219
M1_APN-Q_like cd09601
Peptidase M1 aminopeptidase N catalytic domain family which includes aminopeptidase N (APN), ...
116-470 1.77e-10

Peptidase M1 aminopeptidase N catalytic domain family which includes aminopeptidase N (APN), aminopeptidase Q (APQ), tricorn interacting factor F3, and endoplasmic reticulum aminopeptidase 1 (ERAP1); This M1 peptidase family includes eukaryotic and bacterial members: the catalytic domains of aminopeptidase N (APN), aminopeptidase Q (APQ, laeverin), endoplasmic reticulum aminopeptidase 1 (ERAP1) as well as tricorn interacting factor F3. Aminopeptidase N (APN; CD13; alanyl aminopeptidase; EC 3.4.11.2), a type II integral membrane protease, preferentially cleaves neutral amino acids from the N-terminus of oligopeptides and is present in a variety of human tissues and cell types (leukocyte, fibroblast, endothelial and epithelial cells). APN expression is dysregulated in inflammatory diseases such as chronic pain, rheumatoid arthritis, multiple sclerosis, systemic sclerosis, systemic lupus erythematosus, polymyositis/dermatomyosytis and pulmonary sarcoidosis, and is enhanced in tumor cells such as melanoma, renal, prostate, pancreas, colon, gastric and thyroid cancers. It is considered a marker of differentiation since it is predominantly expressed on stem cells and on cells of the granulocytic and monocytic lineages at distinct stages of differentiation. Thus, APN inhibition may lead to the development of anti-cancer and anti-inflammatory drugs. ERAP1, also known as endoplasmic reticulum aminopeptidase associated with antigen processing (ERAAP), adipocyte derived leucine aminopeptidase (A-LAP), or aminopeptidase regulating tumor necrosis factor receptor I (THFRI) shedding (ARTS-1), associates with the closely related ER aminopeptidase ERAP2, for the final trimming of peptides within the ER for presentation by MHC class I molecules. ERAP1 is associated with ankylosing spondylitis (AS), an inflammatory arthritis that predominantly affects the spine. ERAP1 also aids in the shedding of membrane-bound cytokine receptors. The tricorn interacting factor F3, together with factors F1 and F2, degrades the tricorn protease products, producing free amino acids, thus completing the proteasomal degradation pathway. F3 is homologous to F2, but not F1, and shows a strong preference for glutamate in the P1' position. APQ, also known as laeverin, is specifically expressed in human embryo-derived extravillous trophoblasts (EVTs) that invade the uterus during early placentation. It cleaves the N-terminal amino acid of various peptides such as angiotensin III, endokinin C, and kisspeptin-10, all expressed in the placenta in large quantities. APN is a receptor for coronaviruses, although the virus receptor interaction site seems to be distinct from the enzymatic site and aminopeptidase activity is not necessary for viral infection. APNs are also putative Cry toxin receptors. Cry1 proteins are pore-forming toxins that bind to the midgut epithelial cell membrane of susceptible insect larvae, causing extensive damage. Several different toxins, including Cry1Aa, Cry1Ab, Cry1Ac, Cry1Ba, Cry1Ca and Cry1Fa, have been shown to bind to APNs; however, a direct role of APN in cytotoxicity has been yet to be firmly established.


Pssm-ID: 341064 [Multi-domain]  Cd Length: 442  Bit Score: 64.91  E-value: 1.77e-10
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 22330618  116 REDTANLLINcckpSKDLSeqLDSVTLENGSQSSGEAKQNVKLIRINYWV----EKIESG------IHFDGNI------- 178
Cdd:cd09601   27 LEPTDTIVLH----AKDLT--ITSASLTLKGGSGIIEVTVVTDEETEFLTitldETLPPGenytlsIEFTGKLnddlrgf 100
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 22330618  179 ---VHTDN----------QM-----RRArcwFPCIDDEYHRCSFDLEFTVPHNFVAVSVGKLLYQVMCKED-------TT 233
Cdd:cd09601  101 yrsSYTDEdgetrylaatQFeptdaRRA---FPCFDEPAFKATFDITITHPKGYTALSNMPPVESTELEDGwktttfeTT 177
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 22330618  234 QK--TYVyelaipiaprwVSLVAGPLEILPDQT--NFLISNLCLPHDLSRLRNTMEFFHEAYSYYEDYLsaNFPFGFYK- 308
Cdd:cd09601  178 PPmsTYL-----------VAFVVGDFEYIESTTksGVPVRVYARPGKIEQGDFALEVAPKILDFYEDYF--GIPYPLPKl 244
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 22330618  309 -QVFLPpemvvtSSTSGA----SLSIF-SSHILYDERVidQTIDTRIKLASA----LAKQWFGVYITPESPNDDWLLDGL 378
Cdd:cd09601  245 dLVAIP------DFAAGAmenwGLITYrETALLYDPKT--SSASDKQRVAEViaheLAHQWFGNLVTMKWWDDLWLNEGF 316
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 22330618  379 AGFLTDMFIKQFLGNNEARYRRYKANCAVCKADDSGAmclSSSP---------SCRDLFGTHSIGmhgkirswKSGAVLQ 449
Cdd:cd09601  317 ATYMEYLAVDKLFPEWNMWDQFVVDELQSALELDSLA---SSHPievpvespsEISEIFDAISYS--------KGASVLR 385
                        410       420
                 ....*....|....*....|.
gi 22330618  450 MLEKQMGSDSFRKILQKIISR 470
Cdd:cd09601  386 MLENFLGEEVFRKGLRKYLKK 406
M1_APN cd09602
Peptidase M1 family including aminopeptidase N catalytic domain; This model represents the ...
171-466 3.00e-07

Peptidase M1 family including aminopeptidase N catalytic domain; This model represents the catalytic domain of bacterial and eukaryotic aminopeptidase N (APN; CD13; alanyl aminopeptidase; EC 3.4.11.2), a type II integral membrane protease belonging to the M1 gluzincin family. APN preferentially cleaves neutral amino acids from the N-terminus of oligopeptides and, in higher eukaryotes, is present in a variety of human tissues and cell types (leukocyte, fibroblast, endothelial and epithelial cells). APN expression is dysregulated in inflammatory diseases such as chronic pain, rheumatoid arthritis, multiple sclerosis, systemic sclerosis, systemic lupus erythematosus, polymyositis/dermatomyosytis and pulmonary sarcoidosis, and is enhanced in tumor cells such as melanoma, renal, prostate, pancreas, colon, gastric and thyroid cancers. It is predominantly expressed on stem cells and on cells of the granulocytic and monocytic lineages at distinct stages of differentiation, thus considered a marker of differentiation. Thus, APN inhibition may lead to the development of anti-cancer and anti-inflammatory drugs. APNs are also present in many pathogenic bacteria and represent potential drug targets. Some APNs have been used commercially, such as one from Lactococcus lactis used in the food industry. APN also serves as a receptor for coronaviruses, although the virus receptor interaction site seems to be distinct from the enzymatic site and aminopeptidase activity is not necessary for viral infection. APNs have also been extensively studied as putative Cry toxin receptors. Cry1 proteins are pore-forming toxins that bind to the midgut epithelial cell membrane of susceptible insect larvae, causing extensive damage. Several different toxins, including Cry1Aa, Cry1Ab, Cry1Ac, Cry1Ba, Cry1Ca and Cry1Fa, have been shown to bind to APNs; however, a direct role of APN in cytotoxicity has been yet to be firmly established.


Pssm-ID: 341065 [Multi-domain]  Cd Length: 440  Bit Score: 54.44  E-value: 3.00e-07
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 22330618  171 GIH-----FDGNI-VHTDNQMRRARCWFPCIDDEYHRCSFDLEFTVPHNFVAVSVGKLLYQVmckEDTTQKTYVYELAIP 244
Cdd:cd09602  104 GLHrfvdpADGETyLYTLFEPDDARRVFPCFDQPDLKATFTLTVTAPADWTVISNGPETSTE---EAGGRKRWRFAETPP 180
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 22330618  245 IAPRWVSLVAGPLEILPDQTNFL-ISNLCLPHDLSRLRNTMEFF---HEAYSYYEDYLSANFPFGFYKQVFLPP------ 314
Cdd:cd09602  181 LSTYLFAFVAGPYHRVEDEHDGIpLGLYCRESLAEYERDADEIFevtKQGLDFYEDYFGIPYPFGKYDQVFVPEfnfgam 260
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 22330618  315 EMVvtsstsGAslsifsshILYDERVI---DQTIDTRIKLAS----ALAKQWFGVYITPESPNDDWLldglagfltdmfi 387
Cdd:cd09602  261 ENP------GA--------VTFRESYLfreEPTRAQRLRRANtilhEMAHMWFGDLVTMKWWDDLWL------------- 313
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 22330618  388 kqflgnNE--ARYRRYKANCAVCKADDS-GAMCLSSSPSCRD---LFGTHSI-----------GMHGKIRSWKSGAVLQM 450
Cdd:cd09602  314 ------NEsfADFMAAKALAEATPFTDAwLTFLLRRKPWAYRadqLPTTHPIaqdvpdleaagSNFDGITYAKGASVLKQ 387
                        330
                 ....*....|....*.
gi 22330618  451 LEKQMGSDSFRKILQK 466
Cdd:cd09602  388 LVALVGEEAFRAGLRE 403
M1_LTA4H cd09599
Peptidase M1 family including Leukotriene A4 hydrolase catalytic domain; This model represents ...
23-258 8.74e-05

Peptidase M1 family including Leukotriene A4 hydrolase catalytic domain; This model represents the N-terminal catalytic domain of leukotriene A4 hydrolase (LTA4H; E.C. 3.3.2.6) and the close homolog cold-active aminopeptidase (Colwellia psychrerythraea-type peptidase; ColAP), both members of the aminopeptidase M1 family. LTA4H is a bifunctional enzyme, possessing an aminopeptidase as well as an epoxide hydrolase activity. The two activities occupy different, but overlapping sites. The activity and physiological relevance of the aminopeptidase is poorly understood while the epoxide hydrolase converts leukotriene A4 (LTA4) into leukotriene B4 (LTB4), a potent chemotaxin that is fundamental to the inflammatory response of mammals. It accepts a variety of substrates, including some opioid, di- and tripeptides, as well as chromogenic aminoacyl-p-nitroanilide derivatives. The aminopeptidase activity of LTA4H is possibly involved in the processing of peptides related to inflammation and host defense. Kinetic analysis shows that LTA4H hydrolyzes arginyl tripeptides with high efficiency and specificity, indicating its function as an arginyl aminopeptidase. Thermodynamic characterization using different biophysical methods shows that structurally distinct inhibitors of the LTA4H occupy different regions of the binding site; while some (RB202, ARM1 and SC57461A) bind to the hydrophobic hydrolase side, both bestatin and captopril are located at the hydrophilic peptidase side. LTB4H overexpression is associated with different pathological conditions and diseases such as cystic fibrosis, coronary heart disease, sepsis, shock, connective tissue disease, and chronic obstructive pulmonary disease. It is also overexpressed in certain human cancers, and has been identified as a functionally important target for mediating anticancer properties of resveratrol, a well-known red wine polyphenolic compound with cancer chemopreventive activity.


Pssm-ID: 341062 [Multi-domain]  Cd Length: 442  Bit Score: 46.68  E-value: 8.74e-05
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 22330618   23 AKVLHQKLFLSIDFKKRQIYGYTELEVSV--PDIGIVGLHAENLGIESVLVDG-EPTVFEYYPHHqnsetesnwnsvsdp 99
Cdd:cd09599   11 VRTTHLDLDLTVDFDKKTISGSATLTLEVlqDGADELVLDTRDLDISSVTVNGgKELKFELGPRD--------------- 75
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 22330618  100 asaadaaameyvgvlkredtanllincckpsKDLSEQLdSVTLENGSQSSGEAKqnvklIRINY----------WVEKI- 168
Cdd:cd09599   76 -------------------------------PVLGSAL-TITLPSPLAKGDTFK-----VKIEYsttpqatalqWLTPEq 118
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 22330618  169 -ESGIHfdgNIVHTDNQMRRARCWFPCIDDEYHRCSFDLEFTVPHNFVAV----SVGKllyqvmcKEDTTQKTYVYELAI 243
Cdd:cd09599  119 tAGKKH---PYLFTQCQAIHARSLFPCQDTPSVKSTYSATVTVPKGLTALmsalRTGE-------KEEAGTGTYTFEQPV 188
                        250
                 ....*....|....*
gi 22330618  244 PIAPRWVSLVAGPLE 258
Cdd:cd09599  189 PIPSYLIAIAVGDLE 203
KLF3_N cd21577
N-terminal domain of Kruppel-like factor 3; Kruppel-like factor 3 (KLF3; also called ...
1041-1144 4.03e-03

N-terminal domain of Kruppel-like factor 3; Kruppel-like factor 3 (KLF3; also called Krueppel-like factor 3 and originally called Basic Kruppel-like Factor/BKLF), was the third member of the KLF family of zinc finger transcription factors to be discovered. KLF3 possesses a wide range of biological impacts on regulating apoptosis, differentiation, and proliferation in various tissues during the entire progression process. It has been proposed as a tumor suppressor in colorectal cancer. It appears to function predominantly as a repressor of transcription, turning genes off by recruiting the C-terminal Binding Protein co-repressors CtBP1 and CtBP2. CtBP docks onto a short motif (residues 61-65) in the N-terminus of KLF3, through the Proline-X-Aspartate-Leucine-Serine (PXDLS) motif. CtBP in turn recruits histone modifying enzymes to alter chromatin and repress gene expression. KLF3 belongs to a family of proteins, called the Specificity Protein (SP)/KLF family, characterized by a C-terminal DNA-binding domain of 81 amino acids consisting of three Kruppel-like C2H2 zinc fingers. These factors bind to a loose consensus motif, namely NNRCRCCYY (where N is any nucleotide; R is A/G, and Y is C/T), such as the recurring motifs in GC and GT boxes (5'-GGGGCGGGG-3' and 5-GGTGTGGGG-3') that are present in promoters and more distal regulatory elements of mammalian genes. Members of the KLF family can act as activators or repressors of transcription depending on cell and promoter context. KLFs regulate various cellular functions, such as proliferation, differentiation, and apoptosis, as well as the development and homeostasis of several types of tissue. In addition to the C-terminal DNA-binding domain, each KLF also has a unique N-terminal activation/repression domain that confers specificity and allows it to bind specifically to a certain partner, leading to distinct activities in vivo. This model represents the N-terminal domain of KLF3.


Pssm-ID: 410554 [Multi-domain]  Cd Length: 214  Bit Score: 40.41  E-value: 4.03e-03
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 22330618 1041 SLDVAPYGVPIIPQEMFMPIVPELMLPEPVAAYdetQHL--------EPRMESQNQPSHENPIVH-EIPSDvegpteela 1111
Cdd:cd21577   81 PPVAPPPLSPGSVPGGLPVISPVMVQPVPVLYP---PHLhqpimvssSPPPDDDHHHHKASSMKPsELGGD--------- 148
                         90       100       110
                 ....*....|....*....|....*....|....
gi 22330618 1112 HREANPPTK-EPQkePDVVSVSVSHEVKKSVIRI 1144
Cdd:cd21577  149 NHELHKPIKtEPR--PEHAQDPYSEEMSSSVISS 180
 
Blast search parameters
Data Source: Precalculated data, version = cdd.v.3.21
Preset Options:Database: CDSEARCH/cdd   Low complexity filter: no  Composition Based Adjustment: yes   E-value threshold: 0.01

References:

  • Wang J et al. (2023), "The conserved domain database in 2023", Nucleic Acids Res.51(D)384-8.
  • Lu S et al. (2020), "The conserved domain database in 2020", Nucleic Acids Res.48(D)265-8.
  • Marchler-Bauer A et al. (2017), "CDD/SPARCLE: functional classification of proteins via subfamily domain architectures.", Nucleic Acids Res.45(D)200-3.
Help | Disclaimer | Write to the Help Desk
NCBI | NLM | NIH